Oyster Point Pharma Q2 EPS $(0.85), Inline
Oyster Point Pharma (NASDAQ:OYST) reported quarterly losses of $(0.85) per share which met the analyst consensus estimate. This is a 28.79 percent decrease over losses of $(0.66) per share from the same period last year.